Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 1.000 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.581 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.539 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.532 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.529 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.528 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.523 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.513 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.503 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.502 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.498 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.497 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.496 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.494 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.490 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.490 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.489 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.485 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.485 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.485 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.483 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.480 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.480 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.480 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.480 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.479 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.477 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.476 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.476 | |
4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.474 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.473 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.473 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.473 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.473 | |
3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.472 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
3t8o | ATP | Rhodopsin kinase | / | 0.469 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.468 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.468 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.464 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
3c4x | ATP | Rhodopsin kinase | / | 0.464 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.463 | |
4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.463 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.462 | |
3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.462 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.460 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.459 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.459 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.458 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.458 | |
4y95 | 746 | Tyrosine-protein kinase | / | 0.458 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.457 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.457 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.456 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.456 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.455 | |
2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.455 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.455 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.454 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.453 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.453 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.453 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
4wbo | ANW | Rhodopsin kinase | / | 0.452 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.450 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.450 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.449 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.449 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.449 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.449 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.448 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.447 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.447 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.447 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.446 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.445 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.445 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.445 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.445 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.445 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.445 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.444 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.444 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.443 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.443 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.442 | |
4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.442 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.442 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.442 | |
2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.441 | |
4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.441 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.441 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.441 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.441 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.440 | |
3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.440 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 |